Press & news - FluoGuide A/S

27 February, 2025 FluoGuide A/S publishes interim report for the period January – December 2024 News English Regulatory Listing Regulation Report Interim Yearend IR

Copenhagen, Denmark, 27 February 2025 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its...

15 January, 2025 FluoGuide A/S receives approval for phase II trial in head and neck cancer News Corporate Information Other Corporate Information English IR

Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in...

27 November, 2024 FluoGuide A/S publishes interim report for the period January – September 2024 News English Regulatory Listing Regulation Report Interim Q3 IR

Copenhagen, Denmark, 27 November 2024 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its...

19 November, 2024 Publication of positive phase II clinical data for FG001 in patients with head and neck cancer News Corporate Action Other English IR

Copenhagen, Denmark, 19 November 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...

12 November, 2024 FluoGuide A/S issue warrants to board member, CMO and CFO News Corporate Action Other English Regulatory Listing Regulation IR

Copenhagen, Denmark, 12 November 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) announces issuing...

21 October, 2024 Roger Gunnarsson resigns as board member due to return to a full-time investment banking career, which precludes him from holding board position in FluoGuide News Corporate Information Other Corporate Information English IR

Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in...

7 October, 2024 FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer News Corporate Information Other Corporate Information English IR

Copenhagen, Denmark - FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in precision...

29 August, 2024 FluoGuide A/S publishes interim report for the period January – June 2024 News English Regulatory Listing Regulation Report Interim Q2 IR

Copenhagen, Denmark, 29 August 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...

26 August, 2024 FluoGuide appoints Jens Ellrich as Chief Medical Officer News Corporate Action Other English Regulatory Listing Regulation IR

Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in...

2025

2024

FluoGuideCalendar & events